Cephalosporins possessing a 1,3-dithiolane, 1,3-dithiane, or 1,3-dithietane ring on their 7p-substituents showed potent inhibitory activity against cephaloridine hydrolysis by cephalosporinases purified from Proteus morganii, Proteus rettgeri, and Proteus inconstans, which were not inhibited by clavulanic acid, a wellknown ,-lactamase inhibitor. The mode of inhibition was competitive. The dithiolane cephalosporins themselves were stable against hydrolysis by the Plactamases'tested. A combination of a dithiolane cephalosporin and cephaloridine synergistically inhibited in vitro growth of strains of P. morganii, P. rettgeri, P.
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Recently, several 3-lactamase inhibitors have been reported. Clavulanic acid is a well-known ,-lactamase inhibitor and has been shown to be synergistic in combination with ampicillin, amoxicillin, or piperacillin (4, 5, 8) . This inhibitor is effective against penicillinases from grampositive bacteria and against some 3-lactamases with penicillinase activity from gram-negative bacteria. However, many cephalosporinasetype ,B-lactamases (cephalosporinases) from gram-negative bacteria are not inhibited by clavulanic acid. Gram-negative bacteria are isolated from clinical sources with high frequency, and a fairly high number of them produce cephalosporinases. Thus, the present study was undertaken to find cephalosporinase inhibitors. Since 7a-methoxy cephalosporin (cephamycin) derivatives have been shown to inhibit such cephalosporinases (3, 7) , we began by testing semisynthetic cephamycin derivatives for their inhibitory activity against cephaloridine hydrolysis by a cephalosporintse purified from a clinical isolate of Proteus morganii. Of the more than 100 cephamycins tested, a compound possessing aIdithiolane moiety in its 7p-substituent showed the stroingest activity. We then examined structural requirements for this activity by testing several analogs of the compound and found that the dithiolane or analogous groups in the 7f-substituent were responsible for'the inhibitory activity.
This Among them, compound 1 showed the most potent activity (Table 1) . This cephamycin has substituents of (1-methyl-lH-tetrazol-5-yl)thiomethyl and 2-ethoxycarbonyl-2-(1,3-dithiolan-2-ylidene)acetamido groups at the 3-and 7-positions, respectively. We then examined a cephalosporin (7a-H) analog of the cephamycin (compound 2, Na salt) and found that the analog had stronger inhibitory activity than the cephamycin. Both compounds 1 and 2 were >10 times Table 2 shows percent inhibitory activities of cephalosporins having a dithiolane moiety in their 713-substituents. Dithiolane cephalosporins having an ester group in their 7,B-amido substituents (compounds 3 to 14) strongly inhibited the cephalosporinase and showed 80% or greater inhibition at a concentration of 10 ng/ml. Dithiolane cephalosporins having an amide group (compounds 15 and 16) or a free carboxyl group (compound 17) also showed inhibitory activity. However, a dithiolane cephalosporin having a cyano group (compound 18) showed no inhibitory activity. Table 3 shows the inhibitory activity of diamide derivatives of 1,3-dithietan-2-ylidene-, 1,3-dithiolan-2-ylidene-, and 1,3-dithian-2-ylidenemalonic acid (compounds 19 to 21). They also showed inhibitory activity. Compounds 22 and 23 ( Fig. 1) did not show inhibitory activity, indicating that the cephalosporin nucleus is essential for the inhibitory activity. Figure  2 shows a Lineweaver-Burk plot in which compound 2 was used as an inhibitor. The mode of inhibition of dithiolane cephalosporins was competitive.
Inhibition of other 1-lactamases by dithiolane cephalosporins. Several dithiolane cephalosporins and clavulanic acid were tested for inhibi- tory activities against cephaloridine hydrolysis by f-lactamases purified from P. morganii, P. rettgeri, P. inconstans, and E. coli (Table 4) . At a concentration of 10 ng/ml, compounds 2, 8, 13, and 14 inhibited the three cephalosporinases from the Proteus species, whereas they showed almost no inhibition against the E. coli enzyme. On the contrary, clavulanic acid inhibited the E. coli enzyme but showed only weak inhibition against the three cephalosporinases.
Stability of a dithiolane cephalosporin against ,-lactamase hydrolysis. Hydrolysis rates of a dithiolane cephalosporin, compound 2, by several 3-lactamases were compared with those of other ,-lactam antibiotics (Table 5) . Compound 2 was stable against hydrolysis by all ,B-lactamases tested and showed relative Vma,, values of <0.1 for each of the enzymes except that of P. vulgaris. Against P. vulgaris enzyme compound 2 was more stable than cefuroxime and cefotaxime, P-lactamase-stable oxyiminocephalosporins.
In vitro synergistic effect of compound 2 with cephaloridine. In vitro synergistic effects of both compound 2 and clavulanic acid with cephalori- [MIC], >50 ,ug/ml) from our stock collection of clinical isolates, were tested by the usual checkerboard titration method (Table 6) . A combination was defined to be synergistic when there was a fourfold or greater reduction in MIC of each compound in combination compared with that of each compound alone. Compound 2 with cephaloridine showed synergistic activity against 11 strains (48%). Among strains that produce a cephalosporinase similar to the P. morganii enzyme (P. rettgeri, P. inconstans, Enterobacter cloacae, Enterobacter aerogenes, Serratia marcescens), the combination was synergistic against 10 of 12 strains. On the contrary, clavulanic acid with cephaloridine was not synergistic against any of these strains, whereas this combination was synergistic against 11 strains of E. coli, Klebsiella pneumoniae, and P. vulgaris. (6) . Vmax values are expressed as a percentage of that with cephaloridine or penicillin G. 1-lactamases) from Proteus species. The common structure required for the inhibitors was determined to be that shown in Fig. 3 . The 3-(1-methyl-lH-tetrazol-5-yl)thiomethyl group in the structure may be replaced by other groups, because some dithiolane cephalosporins having other 3-substituents showed similar inhibitory activity (data not shown). The R in Fig. 3 Clavulanic acid has been shown to inhibit ,-lactamases of certain types (2, 5) . It shows strong inhibitory activity against most of the penicillinase-type ,-lactamases but almost no activity against type I P-lactamases. A penicillanic acid sulfone, CP-45,899, is another 1-lactamase inhibitor and has been shown to have inhibitory activity against hydrolysis by Richmond type II, III, and V 3-lactamases (2). However, the inhibitory activity of this inhibitor against type I 13-lactamases is also low. A 13-lactamase-stable cephalosporin, cefotaxime, is known to inhibit type I 3-lactamases. Fu and Neu (2) examined the synergistic activity of cefotaxime in combination with piperacillin against strains of Serratia, Enterobacter, Citrobacter, Proteus, and Pseudomonas, which often produce type I 3-lactamases. The combination, however, was not synergistic against any of the strains but rather was antagonistic against some of them. On the contrary, dithiolane cephalosporins strongly inhibited type I 1-lactamases, and the combination of a dithiolane cephalosporin (compound 2) and cephaloridine showed synergistic activity against P. morganii, P. rettgeri, P. inconstans, Enterobacter aerogenes, Enterobacter cloacae, and S. marcescens, as expected from the P-lactamase-inhibitory activity of the compound. It should be stressed that the synergy was shown among strains of gram-negative bacterial species often reported to be opportunistic pathogens and producers of cephalosporinases that are not inhibited by clavulanic acid.
Since the mode of inhibition was competitive, dithiolane cephalosporins may bind to the active site of the enzymes. Thus, we tested the stability of a dithiolane cephalosporin, compound 2, against hydrolysis by several ,-lactamases and found that the compound was stable against hydrolysis by all P-lactamases tested except that of P. vulgaris. Against hydrolysis by the P. vulgaris enzyme, compound 2 was more stable than cefuroxime and cefotaxime, but less stable than a cephamycin, cefmetazole.
The in vitro antibacterial activities of some dithiolane cephalosporins have been tested. Compound 2 had the most potent activity and showed MICs of 3.1 ,ug/ml for Staphylococcus aureus 209P, 6.2 ,ug/ml for E. coli NIHJ JC-2 and Shigella flexneri 2a, 12.5 ,ug/ml for Salmonella enteritidis Gaertner, and 25 ,ug/ml for Klebsiella pneumoniae. The compound was inactive against Pseudomonas aeruginosa (MIC, >400 ,ug/ml). MICs of other dithiolane cephalosporins and related compounds were similar to or less than those of compound 2.
